Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Nuvo Pharmaceuticals Inc MRVFF

Healthcare Drug Manufacturers - Specialty & Generic
Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets. see more

Bullboard (OTCQX:MRVFF)

View:
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Next
Comment by lscfaon May 17, 2021 2:33pm

RE:RE:RE:Loan balance May 2021

You don't get it. EV is independent of capital structure.     2021 ebitda  20.0 20.0 Multiple  ...more  
220
Discussion
Comment by UglyKidStockon May 17, 2021 12:58pm

RE:RE:Loan balance May 2021

Market cap doesn't look at your balance sheet . It is strictly based on the emotions of  stock traders.  Share price times number of shares.     EV is how much you could ...more  
164
Discussion
Comment by lscfaon May 17, 2021 12:35pm

RE:Loan balance May 2021

EV is based on ebitda.  If debt component declines, market cap component goes up.
150
Discussion
Post by UglyKidStockon May 17, 2021 11:42am

Loan balance May 2021

Paid loan down 3 percent.    This should be standard every quarter going forward .    Loan goes down which brings enterprise value down which should bring stock price up.   ...more  
246
Discussion
Post by Marathon11on May 06, 2021 9:44pm

Bought Deal

In my opinion... trading suggests we are in a 60 or 90 day average price bought deal exercise. Will see.
208
Post by UglyKidStockon Apr 22, 2021 11:07am

Putting up a Shelf

Is this a smart as a fox move or a signal of danger.    This filing gives them the opportunity to sell 40 million in shares anytime in the next 12 months.    If management is ...more  
225
Post by UglyKidStockon Apr 08, 2021 8:10am

CEO buying

Good sign to see insider trading starting to happen again.    CEO Jessie Ledger on March 2021 https://www.canadianinsider.com/company-insider-filings?ticker=MRV
214
Post by UglyKidStockon Mar 25, 2021 12:13am

Good Presentation

Debt goes down each year by 10- 15 million and revenues and profits go up.   Each quarter going forward the balance sheet will look better than the last.   If no hiccups $3/share by 2022 ...more  
268
Comment by UglyKidStockon Mar 23, 2021 3:55am

RE:Vimovo Litigation

Feb 2021 -   Dr Reddy motion for summary dismissal Denied.    Litigation goes forward.   No timetable https://casetext.com/case/horizon-medicines-llc-v-dr-reddys-labs-inc-2
195
Discussion
Comment by ValueCapon Mar 15, 2021 11:37pm

RE:Vimovo Litigation

The litigation timeline probably got delayed a bit due to covid, but q2-3 i'm sure will be done.  They could see a windfall payment likely for damages by DRL.  The prospectus filing ...more  
231
Discussion
Post by Marathon11on Mar 15, 2021 8:14am

Vimovo Litigation

From a 2019 PR re Dr. Reddy's and the 996 and 920 patents: "The parties have mutually agreed on a pre-trial litigation schedule with the court through to April 2021." Should we hear ...more  
277
Discussion
Post by lscfaon Mar 10, 2021 10:16am

Bloom raises target price

We have updated our forecasts based on 4Q-2020 results and expectation of increased sales and S,G&A as COVID-19 abates and Miravo moves forward with multiple product launches. We are also rolling ...more  
330
Discussion
Comment by ronzon Mar 09, 2021 8:41am

RE:RE:RE:Good leverage

Shouldn't they be addressing the debt first from their last acquistion? Their business model isn't great. Their only option appears to start printing shares.... Sounds a lot more like the old ...more  
175
Discussion
Comment by lscfaon Mar 08, 2021 11:53pm

RE:RE:Good leverage

The warrants have a $3.53 exercise price and won't be exercised any time soon. The $40 million prospectus has a 2 year shelf life and suggests they want to be ready in case an acquistion presents ...more  
170
Discussion
Comment by Marathon11on Mar 08, 2021 8:56pm

RE:Good leverage

What are your thoughts on the 25M+ warrants and the $40M prospectus and the fact that only BB covers this? I'm still acquiring.
127
Discussion
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities